ALRN

Aileron Therapeutics, Inc.

Healthcare

Set alert

Price alert · ALRN

All alert types
2.11 0.00 0.00%
As of Jan 10, 2025
1.96 Day range 2.17

52-week range unavailable

Open
1.97
Prev close
2.11
Mkt cap
47.02M
Vol
63.39K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.96
High
2.17
Forward P/E
-1.22
Beta
2.34
Short ratio
3.47
Inst. own
28.47%
Dividend
0.00
Ex-div date
50-d avg
3.03
200-d avg
3.47
1y target
13.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ALRN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-7.86 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2016: -6.5×FY 2017: -6.9×FY 2018: -0.4×FY 2019: -0.5×FY 2020: -1.7×FY 2021: -1.9×FY 2022: -0.4×FY 2023: -0.9×FY 2024: -0.7×FY 2025: -1.0×
FY 2016 5y median -0.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.1×
FY 2016: -1.1×FY 2017: 3.2×FY 2018: 0.6×FY 2019: 0.9×FY 2020: 3.0×FY 2021: 1.1×FY 2022: 0.6×FY 2023: 2.0×FY 2024: 0.8×FY 2025: 3.1×
FY 2016 5y median 1.1× FY 2025
P/FCF -2.7×
FY 2016: -7.9×FY 2017: -7.5×FY 2018: -0.4×FY 2019: -0.5×FY 2020: -1.8×FY 2021: -2.1×FY 2022: -0.4×FY 2023: -0.7×FY 2024: -1.9×FY 2025: -2.7×
FY 2016 5y median -1.9× FY 2025
EV/EBITDA 48947×
FY 2016: -5.4×FY 2017: -6.4×FY 2018: -0.2×FY 2019: -0.5×FY 2020: -1.5×FY 2021: -1.8×FY 2022: -0.2×FY 2023: 0.2×FY 2024: 451×FY 2025: 48947×
FY 2016 5y median 0.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -37.1%
FY 2016: -12.7%FY 2017: -13.3%FY 2018: -261.3%FY 2019: -189.4%FY 2020: -56.5%FY 2021: -47.8%FY 2022: -231.1%FY 2023: -141.2%FY 2024: -54.0%FY 2025: -37.1%
FY 2016 5y median -54.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -294.8%
FY 2016: 16.2%FY 2017: -47.3%FY 2018: -161.0%FY 2019: -179.3%FY 2020: -179.4%FY 2021: -58.7%FY 2022: -145.0%FY 2023: -228.4%FY 2024: -115.6%FY 2025: -294.8%
FY 2016 5y median -145.0% FY 2025
ROIC -281.6%
FY 2016: -101.2%FY 2017: -48.1%FY 2018: -127.9%FY 2019: -142.1%FY 2020: -163.3%FY 2021: -59.4%FY 2022: -148.2%FY 2023: -16.0%FY 2024: -115.4%FY 2025: -281.6%
FY 2016 5y median -115.4% FY 2025
ROA -206.4%
FY 2016: -82.3%FY 2017: -42.9%FY 2018: -104.1%FY 2019: -108.7%FY 2020: -133.5%FY 2021: -53.1%FY 2022: -122.7%FY 2023: -14.8%FY 2024: -101.1%FY 2025: -206.4%
FY 2016 5y median -101.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 22.2%
FY 2016: -40.9%FY 2017: -26.6%FY 2018: -38.7%FY 2019: 6.1%FY 2020: 31.6%FY 2021: -29.8%FY 2022: -3.9%FY 2023: 41.1%FY 2024: -300.0%FY 2025: 22.2%
FY 2016 FY 2025
EPS (diluted) 44.2%
FY 2016: -40.7%FY 2017: 7.6%FY 2018: -39.4%FY 2019: 45.2%FY 2020: 46.6%FY 2021: 53.7%FY 2022: -2.6%FY 2023: 42.5%FY 2024: -2.6%FY 2025: 44.2%
FY 2016 FY 2025
Free Cash Flow 13.1%
FY 2016: -27.2%FY 2017: -37.7%FY 2018: -56.5%FY 2019: 17.7%FY 2020: 23.1%FY 2021: -16.7%FY 2022: -4.0%FY 2023: 20.3%FY 2024: -12.5%FY 2025: 13.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.7×
FY 2016: 5.2×FY 2017: 10.6×FY 2018: 4.1×FY 2019: 3.3×FY 2020: 4.1×FY 2021: 10.7×FY 2022: 6.5×FY 2023: 4.2×FY 2024: 2.4×FY 2025: 0.7×
FY 2016 5y median 4.2× FY 2025
Quick Ratio 0.7×
FY 2016: 5.2×FY 2017: 10.6×FY 2018: 4.1×FY 2019: 3.3×FY 2020: 4.1×FY 2021: 10.7×FY 2022: 6.5×FY 2023: 4.2×FY 2024: 2.4×FY 2025: 0.7×
FY 2016 5y median 4.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.3×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -3215×
FY 2016: 1.2×FY 2017: 0.5×FY 2018: 0.2×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 1.1×FY 2024: -204×FY 2025: -3215×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31